Q1 2019 Holdings
Filed 2019-05-14 | 22 holdings | $599.8M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2019-08-22) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $378.9M | 12,041,419 | 63.2% |
| Agios Pharmaceuticals Inc(AGIO) | Common | 00847X104 | $149.3M | 2,214,459 | 24.9% |
| Biogen Inc(BIIB) | Common | 09062X103 | $70.9M | 300,040 | 11.8% |
| Theravance Biopharma Inc(TBPH) | Common | G8807B106 | $303.3K | 13,379,979 | 0.1% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $144.6K | 11,924,614 | 0.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $96.3K | 2,639,676 | 0.0% |
| Nucana PLC | SPON ADR | 67022C106 | $54.9K | 3,230,999 | 0.0% |
| Evofem Biosciences Inc(NEOTEUR) | Common | 30048L104 | $40.4K | 11,543,728 | 0.0% |